1. Home
  2. AIRE vs CALC Comparison

AIRE vs CALC Comparison

Compare AIRE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$0.25

Market Cap

39.9M

Sector

N/A

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.57

Market Cap

9.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
CALC
Founded
2021
2011
Country
United States
United States
Employees
N/A
16
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
9.3M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
AIRE
CALC
Price
$0.25
$0.57
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$1.25
$10.00
AVG Volume (30 Days)
1.4M
283.5K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
60.34
N/A
EPS
N/A
N/A
Revenue
$4,518,498.00
N/A
Revenue This Year
$168.41
N/A
Revenue Next Year
$79.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
376.42
N/A
52 Week Low
$0.14
$0.46
52 Week High
$1.55
$7.20

Technical Indicators

Market Signals
Indicator
AIRE
CALC
Relative Strength Index (RSI) 37.01 34.86
Support Level $0.14 $0.49
Resistance Level $0.35 $0.79
Average True Range (ATR) 0.02 0.08
MACD -0.00 0.04
Stochastic Oscillator 23.86 16.43

Price Performance

Historical Comparison
AIRE
CALC

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

Share on Social Networks: